WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2004006849) COMBINATIONS OF DRUGS FOR THE TREATMENT OF NEOPLASMS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2004/006849    International Application No.:    PCT/US2003/021984
Publication Date: 22.01.2004 International Filing Date: 15.07.2003
Chapter 2 Demand Filed:    15.01.2004    
IPC:
A61K 31/00 (2006.01), A61K 45/06 (2006.01)
Applicants: COMBINATORX, INCORPORATED [US/US]; 650 Albany Street, Boston, MA 02118 (US) (For All Designated States Except US).
BORISY, Alexis [US/US]; (US) (For US Only).
KEITH, Curtis [CA/US]; (US) (For US Only).
FOLEY, Michael, A. [US/US]; (US) (For US Only).
STOCKWELL, Brent, R. [US/US]; (US) (For US Only).
GAW, Debra, A. [US/US]; (US) (For US Only)
Inventors: BORISY, Alexis; (US).
KEITH, Curtis; (US).
FOLEY, Michael, A.; (US).
STOCKWELL, Brent, R.; (US).
GAW, Debra, A.; (US)
Agent: CLARK, Paul, T.; Clark & Elbing LLP, 101 Federal Street, Boston, MA 02110 (US)
Priority Data:
60/396,151 15.07.2002 US
Title (EN) COMBINATIONS OF DRUGS FOR THE TREATMENT OF NEOPLASMS
(FR) COMBINAISONS DE MEDICAMENTS POUR LE TRAITEMENT DE NEOPLASMES
Abstract: front page image
(EN)The invention features a method for treating a patient having a cancer or other neoplasm, by administering to the patient (i) a benzimidazole or a metabolite or analog thereof; and (ii) pentamidine or a metabolite or analog thereof simultaneously or within 14 days of each other in amounts sufficient to inhibit the growth of the neoplasm.
(FR)L'invention concerne une méthode de traitement d'un patient présentant un cancer ou autre néoplasme, par administration au patient (i) d'un benzimidazole ou un métabolite ou analogue de ce dernier; et (ii) de la pentamidine ou un métabolite ou analogue de cette dernière, simultanément ou à 14 jours d'intervalle, dans des quantités suffisantes pour inhiber la croissance du néoplasme.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LU, MC, NL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)